Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2018 | 2 |
2020 | 2 |
2021 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
J Clin Invest. 2020 Aug 3;130(8):4266-4281. doi: 10.1172/JCI131572.
J Clin Invest. 2020.
PMID: 32427578
Free PMC article.
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions.
Sucker A, Zhao F, Pieper N, Heeke C, Maltaner R, Stadtler N, Real B, Bielefeld N, Howe S, Weide B, Gutzmer R, Utikal J, Loquai C, Gogas H, Klein-Hitpass L, Zeschnigk M, Westendorf AM, Trilling M, Horn S, Schilling B, Schadendorf D, Griewank KG, Paschen A.
Sucker A, et al. Among authors: pieper n.
Nat Commun. 2017 May 31;8:15440. doi: 10.1038/ncomms15440.
Nat Commun. 2017.
PMID: 28561041
Free PMC article.
Item in Clipboard
Evolution of melanoma cross-resistance to CD8+ T cells and MAPK inhibition in the course of BRAFi treatment.
Pieper N, Zaremba A, Leonardelli S, Harbers FN, Schwamborn M, Lübcke S, Schrörs B, Baingo J, Schramm A, Haferkamp S, Seifert U, Sucker A, Lennerz V, Wölfel T, Schadendorf D, Schilling B, Paschen A, Zhao F.
Pieper N, et al.
Oncoimmunology. 2018 Apr 18;7(8):e1450127. doi: 10.1080/2162402X.2018.1450127. eCollection 2018.
Oncoimmunology. 2018.
PMID: 30221038
Free PMC article.
Item in Clipboard
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.
López-Cobo S, Pieper N, Campos-Silva C, García-Cuesta EM, Reyburn HT, Paschen A, Valés-Gómez M.
López-Cobo S, et al. Among authors: pieper n.
Oncoimmunology. 2017 Nov 6;7(2):e1392426. doi: 10.1080/2162402X.2017.1392426. eCollection 2018.
Oncoimmunology. 2017.
PMID: 29308322
Free PMC article.
Item in Clipboard
A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4+ and CD8+ T Cells in COVID-19 Patients.
Zelba H, Worbs D, Harter J, Pieper N, Kyzirakos-Feger C, Kayser S, Seibold M, Bartsch O, Ködding J, Biskup S.
Zelba H, et al. Among authors: pieper n.
J Immunol. 2021 Feb 1;206(3):580-587. doi: 10.4049/jimmunol.2000811. Epub 2020 Dec 9.
J Immunol. 2021.
PMID: 33298615
Item in Clipboard
Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
Zelba H, Kyzirakos C, Kayser S, Shao B, Reinhardt A, Pieper N, Rabsteyn A, Döcker D, Armeanu-Ebinger S, Kloor M, Hadaschik D, Schulze M, Battke F, Golf A, Biskup S.
Zelba H, et al. Among authors: pieper n.
Vaccines (Basel). 2024 Apr 9;12(4):397. doi: 10.3390/vaccines12040397.
Vaccines (Basel). 2024.
PMID: 38675779
Free PMC article.
Item in Clipboard
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
Blumendeller C, Boehme J, Frick M, Schulze M, Rinckleb A, Kyzirakos C, Kayser S, Kopp M, Kelkenberg S, Pieper N, Bartsch O, Hadaschick D, Battke F, Stenzl A, Biskup S.
Blumendeller C, et al. Among authors: pieper n.
J Immunother Cancer. 2021 Jan;9(1):e001406. doi: 10.1136/jitc-2020-001406.
J Immunother Cancer. 2021.
PMID: 33431630
Free PMC article.
Item in Clipboard
Cite
Cite